Bottom line
CURE vs ELIL: the short answer
CURE (Direxion Daily Healthcare Bull 3X ETF) and ELIL (Direxion Daily LLY Bull 2X ETF) are both etfs.
But CURE is far broader, holding 67 positions to 9 for ELIL, so beyond the top names it adds exposure ELIL doesn't have.
CURE is cheaper at 0.94% vs 1.07% — a difference of $13 a year per $10,000 invested.
Updated Nov 19, 2026
CURE vs ELIL side by side
| CURE | ELIL | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.94% | 1.07% |
| Annual cost per $10k | $94 | $107 |
| 10-yr cost on $10k (prospectus) | $1,155 | $1,558 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +22.9% | — |
| 5-yr return (annualized) | +8.6% | — |
| 10-yr return (annualized) | +13.6% | — |
| Best quarter | +46.9% | — |
| Worst quarter | −45.8% | — |
| Net assets (fund) | $171.7M | $18.3M |
| Number of holdings | 67 | 9 |
| Portfolio turnover | 1% | % |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
7 of CURE's top 25 holdings also appear in ELIL's top 9.
| Holding | CURE | ELIL |
|---|---|---|
| Dreyfus | 18.79% | 15.35% |
| Eli Lilly & Company | 10.41% | 15.09% |
| N/a | 8.28% | -4.85% |
| Goldman Sachs Liq Es Fd A | 8.19% | 32.52% |
| Goldman Financial | 7.51% | 14.01% |
| N/a | 3.34% | -4.85% |
| N/a | 1.12% | -4.85% |
Source: SEC Form N-PORT
CURE top 10
- Dreyfus — 18.79%
- Eli Lilly & Company — 10.41%
- N/a — 8.28%
- Goldman Sachs Liq Es Fd A — 8.19%
- Goldman Financial — 7.51%
- Johnson & Johnson — 7.07%
- Abbvie Inc — 5.08%
- Unitedhealth Group Inc — 4.31%
- Merck & Company Inc — 3.68%
- N/a — 3.34%
ELIL top 10
- Goldman Sachs Liq Es Fd A — 32.52%
- Dreyfus — 25.97%
- Dreyfus — 15.35%
- Eli Lilly & Company — 15.09%
- Goldman Financial — 14.01%
- N/a — 0.82%
- N/a — 0.17%
- N/a — -2.96%
- N/a — -4.85%
FAQ
What is the difference between CURE and ELIL?
CURE (Direxion Daily Healthcare Bull 3X ETF) and ELIL (Direxion Daily LLY Bull 2X ETF) are both etfs. But CURE is far broader, holding 67 positions to 9 for ELIL, so beyond the top names it adds exposure ELIL doesn't have.
Which is cheaper, CURE or ELIL?
CURE has the lower expense ratio (0.94%).
Should I own both CURE and ELIL?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.